ImaginAb
PrivateLast Round
Series C
Extension
Sep 14, 2023
Total Funding Raised
$49.8M
Company Overview
ImaginAb, Inc. is a clinical-stage biotechnology company that develops radiopharmaceutical imaging agents and therapies. The company engineers antibody fragments, known as "minibodies," which are designed for use with Positron Emission Tomography (PET) imaging to provide non-invasive, whole-body visualizations of immune activity. This technology aims to improve patient selection for cancer immunotherapies and monitor treatment progress. Founded in 2007, the company's lead product is the CD8 ImmunoPET imaging agent (zirconium Zr 89 crefmirlimab berdoxam), which is in Phase 2 clinical trials. In January 2025, ImaginAb sold a pipeline of therapeutic candidates and its protein engineering platform to Telix Pharmaceuticals to focus its resources on the development and commercialization of its CD8 platform. The company is backed by venture capital and strategic corporate firms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImaginAb Comps
Public and private peers based on sector, stage, and business model.
ImaginAb Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 14, 2023 | ||||
| Series C Extension | Mar 14, 2023 | ||||
| Series C | Jun 3, 2021 | ||||
| VC Round | Oct 9, 2017 | ||||
| Series B | May 8, 2014 | ||||
Series A | Mar 26, 2012 |
ImaginAb Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Norgine Ventures | Series C |
| Momentum Biosciences | Series A |
| Parker Institute for Cancer Immunotherapy | VC Round |
| Innoviva | Series C Extension |
| Cycad Group | Series A, VC Round, Series B, Series C |
| Nextech Invest | Series A, VC Round, Series B |
ImaginAb Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImaginAb's valuation, stock price, and market status.
